Until there's a cure ... there's care

MND researcher in laboratory
Dr Peter Crouch, University of Melbourne

By Dr Peter Crouch, University of Melbourne

Clinical outcomes for copper-ATSM as a treatment for MND have very recently been reported in the media, with some of the reports describing exciting results for efficacy.

We all desperately hope for the day when any person diagnosed with MND can be prescribed a drug that will stop the disease in its tracks. Copper-ATSM may one day prove to be that drug, but we’re not there yet. Here, we provide a brief update on copper-ATSM.

The development of copper-ATSM as a treatment option for MND started around 15 years ago when it and related compounds were tested in animal models of neurodegenerative disease. Over the years, the laboratory-based evidences supportive of copper- ATSM being an effective treatment accumulated to the extent where clinical testing in MND patients became a legitimate possibility. It was given to MND patients as a therapeutic for the first time in 2016 when the phase 1 testing commenced. In December 2018, outcomes from the phase 1 trial were announced at the International ALS/MND Symposium in Glasgow, and in January 2019 the same information was circulated as a press release from the company supporting the clinical testing, Collaborative Medicinal Development.

First and foremost, the phase 1 trial was a success. The primary objective, as per any phase 1 trial, was to assess safety and tolerability of the drug and, if possible, identify a dose that could be taken to the next round of testing. By assessing the drug at a number of different doses the trial successfully identified a safe and recommended dose for phase 2 testing. Many potential drugs that show promise in the research laboratory ultimately fail to get through phase 1 testing, so for copper-ATSM to get past this important milestone is an excellent achievement.

In addition to confirming that the drug is safe, reporting on the phase 1 trial also included descriptions of efficacy, such as improved respiratory function and a slowing of disease progression as assessed by the ALSFRS-R scoring system. These are very exciting indications that copper-ATSM may prove to be an effective drug for MND. However, the number of patients included in phase 1 testing (for any drug) is kept small by necessity, and phase 1 trials are not designed to demonstrate efficacy. For example, all patients in the phase 1 trial knowingly receive the drug and there is no placebo control group for direct comparison. So, while the phase 1 results for copper- ATSM are very encouraging and are good cause for excitement, there is still a considerable amount of work to do before it can be confirmed that copper- ATSM is an effective treatment for MND.

It is therefore very welcome news to hear that planning for copper-ATSM to enter phase 2 testing is already underway. Phase 2 trials are specifically designed to assess efficacy. It is reported that the phase 2 testing will start in the second half of 2019 and that the trial will include 80 MND patients. Details of the phase 2 trial, including the participating clinics and the patient recruitment criteria, are yet to be announced.

Upon completion of the phase 2 testing we all hope that the promising indications from the phase 1 trial are confirmed as a reality.

Further discussion of the phase 1 trial for copper- ATSM can be found here: www.mndresearch.blog/2019/01/15/whats-the-story-with-cuatsm

Further information is on the MND Australia website at: https://www.mndaust.asn.au/News-and-media/MND-in-the-news.aspx


Read more MND news:

/MND%20Week%202019%20-%20Help%20Make%20Aged%20Care%20Fair!
Join our campaign to help make aged care fair for older Australians who face long waiting lists for disability care ...
/Meet%20our%20NEW%20CEO,%20Kate%20Johnson!
Kate has enjoyed over 20 years’ experience in leadership and the strategic development of not for-profit organisations ...
/MND%20News%20|%20March-April%202019
Catch up with all the latest from MND Victoria as well as your MND stories, research updates and farewell to Rod Harris, CEO.
/Tasmanian%20Health%20Professional%20Forum
On 1 March nearly 70 people, including speakers and staff, attended the MND Health Professional Forum in Tasmania.
/Benalla%20puts%20MND%20research%20projects%20on%20the%20map
Over 500 people from Benalla, surrounding communities and families affected by MND attended the Act2D'feet MND last weekend.
/An%20incredible%20$250,000%20raised%20from%202018%20Walks
In an amazing result, the funds raised from our 2018 Walk to D'feet MND in Rosebud, Melbourne, Bendigo and Echuca is over $250,000!
/Copper-ATSM%20Update%20-%20Research%20News
Dr Peter Crouch, University of Melbourne researcher updates us on the clinical outcomes for copper-ATSM as recently reported in the media.
/Behind%20the%20Scenes%20at%20our%20Equipment%20Warehouse
Our Equipment Warehouse is a critical part of our services and makes an enormous difference to the lives of people with MND.
/Largest%20MND%20Medical%20&%20Scientific%20Conference
An exclusive report by our CEO on the Allied Professionals Forum, International Symposium on ALS/ MND and other meetings.
/Benalla%20Act%202%20D'feet%20MND%20|%2024%20February%202019
The annual Benalla Act 2 Dfeet MND Walk/Run/Cycle will be held THIS Sunday (24 February) at Benalla Lake.
/MND%20News%20|%20January-February%202019
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20November-December%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20September-October%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20July-August%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/Research%20opportunity:%20Project%20Train-ALS
Researcher opportunity to explore the role of personalised exercise training in patients with MND ...
/Research%20into%20cognitive%20change%20&%20people%20with%20MND
The focus of our neuropsychology research is to understand more about specific changes in cognition, behaviour and mood ...
/There%20are 40%20trillion%20cells%20in%20our%20body%20...
Associate Prof Justin P. Rubio, University of Melbourne, is studying the genomes of single neurons to understand MND ...
/MND%20News%20|%20May-June%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/Ask%20the%20Experts%20Research%20Seminar%202017
‘Ask the Experts’ was held on Tuesday 8 May 2018 in MND Week at the Florey Institute in Parkville ...
/Make%20Aged%20Care%20Fair%20for%20people%20with%20MND!
Aged Care is failing people with motor neurone disease - we need you to join our MND Action Campaign:
/MND%20News%20|%20March-April%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20Australia%20Research%20Conference%202017
Over 160 dedicated MND researchers and supporters attended this conference held at University of Sydney.
/MND%20News%20|%20January-February%202018
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/Research%20Update%20|%20November/December%202017
Find out about preclinical and current trials of medication being offered to patients with ALS/MND ...
/MND%20News%20|%20November/December%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20September/October%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20July/August%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/Voluntary%20assisted%20dying%20and%20MND
We are working to ensure that people with MND aren’t discriminated against if the proposed reforms take place.
/MND%20News%20|%20May/June%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20March/April%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.
/MND%20News%20|%20January/February%202017
Catch up with all the latest from MND Victoria as well as your MND stories and research updates.